JPRN-UMIN000000597
Unknown
Phase 4
A multicenter, randomized controlled trial of entecavir treatment for the patients with hepatocellular carcinoma complicated with chronic hepatitis B or cirrhosis after a curative treatment of the cancer: Anti-virus effect, influence on hepatic reserve, cancer recurrence, and survival. - Effect of entecavir treatment on cancer recurrence after a curative therapy of hepatocellular carcinoma complicated with chronic hepatitis B or cirrhosis.
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 sites170 target enrollmentAugust 1, 2007
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Chronic hepatitis B and cirrhosis after a curative treatment of hepatocellular carcinoma
- Sponsor
- Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- Enrollment
- 170
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)The patients who has an allergy against nucleos(t)ide analogues(2\)The patients who have received interferon or nucleoside analogue within 6 months before registration(3\) Pregnant women, or women who are nursing.(4\)The patients with other chronic liver disease, such as autoimmune hepatitis, primary biliary cirrhosis, alcoholic hepatitis, or chronic hepatitis C.(5\)The patients with an uncontrollable heart trouble (myocardial infarction, heart failure, or arrhythmia)(6\)The patients with chronic renal failure or chronic respiratory failure(7\)The patients who were thought to be inapproriate for this study by the doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A multi-center, randomized, controlled trial on the efficacy and safety of metal stents for biliary drainage prior to pancreatic cancer surgerypancreatic cancerJPRN-UMIN000032076Juntendo University200
Not yet recruiting
Phase 4
A multicenter, randomized, controlled, trial for efficacy of Chang-Yan-Ning granules in the treatment of functional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)functional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)ITMCTR2000002901Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Not yet recruiting
Phase 1
A multicenter, randomized, controlled trial for a novel vaginal microecologic therapy for the treatment of persistent cervical human papillomavirus infection at high riskITMCTR2000003652Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Completed
Not Applicable
The clinical and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shockSevere sepsis/septic shockInfections and InfestationsOther septicaemiaISRCTN36307479Intensive Care National Audit and Research Centre (ICNARC) (UK)1,260
Recruiting
Phase 1
A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategysevere novel coronavirus pneumonia (COVID-19)ITMCTR2000003002Huangshi Hospital of Traditional Chinese Medicine